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1-(Substituted-1-ylmethyl)indoline-2,3-dione 1a-c have been synthesized from different types of secondary amine with 
isatin and formaldehyde in alcohol. The compound 1 have then been converted to the respective compound 2a-g (Z)3-(4-
subsitutedphenylimino)-1-(substituted-1-ylmethyl)indolin-2-one by treatment with different types of primary amines. 
Interaction of compound 2 with thioglycolic acid and chloro acetyl chloride results in cyclization to give compound spiro 
isatin derivatives compounds 3a-g. The anti-microbial activity screening of novel spiro isatin substituted compounds have 
also been carried out.  
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Designing and synthesis of some novel heretocyclic 
Spiro-thiazole compounds showing good pharma-
cological and antimicrobial activity are reported here. 
The presence of Schiff base and isatin moiety in this 
series of compounds enhances the microbial activity 
further. Schiff bases have been extensively used as the 
substrates in the preparation of a number of industrial 
and biologically active compounds. On the other 
hand, isatin and its derivatives are versatile lead 
molecules as the potential bioactive agent because 
they exhibit broad spectrum of activity like anti-
fungal1, 2, antiviral3, anti-mycobacterial4, anti-
inflamatory5, anti-convulsant6, anti-cancer7, 8, anti-
tubercular9, 10, anti-HIV11, 12, etc. The five membered 
heterocyclic ring containing nitrogen and sulfur has 
always been a subject of mystery for researchers 
because of wide range of heterocycles explored as the 
privileged candidates in drug discovery. Thiazoles 
have been identified to play a necessary role in 
medicinal chemistry13. Its derivatives display a wide 
range of biological activities such as cardiotonic, 
fungicidal, sedative, anesthetic, bactericidal and anti-
inflammatory14, 15. As per the extensive literature 
review, it can be found a lot of reports about the spiro 
compounds related to Schiff bases. In addition, spiro 
compounds are also reported from Schiff base with 
isatin moiety and most of the compounds having 
biological importance. Thus it was thought to  
study spiro compounds based on isatin moiety16.  
The biological data drive us to synthesize new spiro 
derivatives bearing thiazole ring. The newly 
synthesized compounds were thoroughly characterized 
by elemental analysis, FTIR, 1H and 13C-NMR.  
 
Experimental Section 
Melting points of all the synthesized compounds 
were determined in open capillary tubes and are 
uncorrected. TLC using silica gel was used to check 
the purity of the compounds.The structure of the 
synthesized compounds was elucidated using FTIR 
8400 spectrophotometer in KBr disc and 1HNMR 
spectra was taken on a Bruker AMX (400MHz)  
FT-NMR.  
 
Synthesis of 1-(substituted-1-ylmethyl)indoline-2,3-
dione 
A mixture of 2º amine (0.001M) and formaldehyde 
(0.01M) by cooling in ice bath. Then warm on water 
bath for 1hr at 70ºC and then add isatine (0.005M) 
and continue heating on water bath up to 2-3 hours at 
80ºC. Then by doing confirm the reaction. Allow it 
for cooling so that crystals are formed. Which are 
filtered, washed with ethanol, dried and the  
melting point is recorded. The compounds of this 
category are presented in Table I along with their 
characterization data.  
 
Synthesis of (Z)3-(4-subsitutedphenylimino)-1-
(substituted-1-ylmethyl)indolin-2-one 
A mixture of 1 (0.02M) and 1º amine (0.02M) in 
anhydrous pyridine (30 ml) was heated under reflux 
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on a sand-bath for 6 hours. Subsequently, the reaction 
mixture was poured into ice-cold water (100 ml) 
containing conc. HCl (10 ml). A solid started to 
separate out which was allowed to settle down for 1 
hour. It was filtered off and washed successively with 
water. After drying in a vacuum desiccator, it was 
recrystallized from ethanol. The compounds of this 
category are presented in Table II along with their 
characterization data.  
 
Synthesis of 3-(4-subsitutedphenylimino) thiazol-
20-yl)-1-(substituted-1-ylmethyl)indolin-2-one 
The target compounds were synthesized in the 
following manner. A mixture of different type of 
methyl indolin-2-one substituted group (0.01mole) 
and thioglycollic acid (0.01mole) containing in trace 
ZnCl2 (0.1 gm) in dimethylformamide (DMF) was 
heated under reflux for 4 hours. It was poured into 
crushed ice and stirred vigorously. Solidification 
occurred after fifteen minutes. It was filtered off and 
washed with cold water. Recrystallization from 
ethanol gave analytically pure sample (Scheme I). 
The compounds of this category are presented in 
Table III along with their characterization data.  
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Table I — Characterization data for compounds 1a-c 
R’ Compd 
 
Mol.  
Formula 
Mol.  
Wt. 
m.p.  
(°C) 
Yield  
(%) 
Morpholine 1a C13H14N2O3 246 179 71 
Piperidine 1b C14H16N2O2 244 182 76 
Diphenyl 
amine 
1c C21H16N2O2 328 118 69 
Table II — Characterization data for compounds 2a-g 
R’ R” Compd Mol. Formula Mol. Wt. m.p. (°C) Yield (%) 
Morpholine 
p-chloro aniline 2a C19H18ClN3O2 355 320 75 
p-bromo aniline 2b C19H18BrN3O2 400 120 78 
p-amino phenol 2c C19H19N3O3 337 60 82 
Piperidine 
p-chloro aniline 2d C20H20ClN3O 353 110 84 
p-bromo aniline 2e C20H20BrN3O 397 118 74 
Diphenyl 
amine 
p-chloro aniline 2f C27H20ClN3O 437 90 72 
p-bromo aniline 2g C27H20BrN3O 482 78 81 
 
Table III — Characterization data for compounds 3a-g 
R’ R” Compd Mol. Formula Mol. Wt. m.p. (°C) Yield (%) 
Morpholine 
p-chloro aniline 3a C21H20ClN3O3S 429 310 84 
p-bromo aniline 3b C21H20BrN3O3S 474 290 75 
p-amino phenol 3c C21H21N3O4S 411 59 81 
Piperidine 
p-chloro aniline 3d C22H22ClN3O2S 427 260 74 
p-bromo aniline 3e C22H22BrN3O2S 472 230 76 
Diphenyl 
amine 
p-chloro aniline 3f C29H22ClN3O2S 512 58 89 
p-bromo aniline 3g C29H22BrN3O2S 556 62 71 
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Results and Discussion 
Thiazol is one of the important heterocyclic 
structures with special significance for the synthesis 
of organic compounds. The spectral data reveals that 
the structures of all the synthesised compounds are in 
good agreement with the proposed ones. N-Mannich 
bases of isatin Schiff bases are formed with the 
supports of secondary amines and Isatin. All the 
synthesized compounds were tested for in vitro 
antibacterial activity. It has been observed that all the 
compounds tested showed mild to moderate activity 
against tested bacteria.   
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